Literature DB >> 2308008

Residual mass and negative gallium scintigraphy in treated lymphoma.

O Israel1, D Front, R Epelbaum, S Ben-Haim, J Jerushalmi, U Kleinhaus, E Even-Sapir, E Robinson.   

Abstract

Two patients with treated lymphoma demonstrated a residual mass on CT following treatment. In both cases gallium-67 (67Ga) scintigraphy demonstrated increased uptake in the original tumor mass and no uptake in the mass after treatment. In both cases the entire residual tumor mass was resected and found to contain no cancer tissue. This is further evidence of the role 67Ga scintigraphy may play in monitoring response of lymphoma patients to treatment. In contrast, other imaging modalities such as ultrasound, plain film x-rays, or CT only show the presence of a mass but not its nature.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2308008

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  5 in total

Review 1.  Recent advances in the diagnosis and therapy of Richter's syndrome.

Authors:  Ronan Swords; John Bruzzi; Francis Giles
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

2.  Performance characteristics of a 511-keV collimator for imaging positron emitters with a standard gamma-camera.

Authors:  A van Lingen; P C Huijgens; F C Visser; G J Ossenkoppele; O S Hoekstra; H J Martens; H Huitink; K D Herscheid; M V Green; G J Teule
Journal:  Eur J Nucl Med       Date:  1992

Review 3.  Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma.

Authors:  Einat Even-Sapir; Ora Israel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-18       Impact factor: 9.236

4.  Residual mass after treatment of primary cervical lymphoma: the utility of gallium 67 and MRI.

Authors:  C J Kasales; J E Langer; C T Young; K Singapuri; P H Arger
Journal:  Abdom Imaging       Date:  1994 May-Jun

Review 5.  Diffuse Large B-Cell Lymphoma in the Era of Precision Oncology: How Imaging Is Helpful.

Authors:  Hina J Shah; Abhishek R Keraliya; Jyothi P Jagannathan; Sree Harsha Tirumani; Vikram R Lele; Pamela J DiPiro
Journal:  Korean J Radiol       Date:  2017-01-05       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.